Regulation of Biotechnological Risks in a Multi-Level System: An Analysis of the EU Regulation of Genome Edited Plants in Light of Wto Law and CETA
暫譯: 多層次系統中生物技術風險的規範：從WTO法與CETA的角度分析歐盟對基因編輯植物的規範
Andersen, Elisabeth Anna Lümkea
- 出版商: Springer
- 出版日期: 2025-11-09
- 售價: $7,460
- 貴賓價: 9.5 折 $7,087
- 語言: 英文
- 頁數: 310
- 裝訂: Hardcover - also called cloth, retail trade, or trade
- ISBN: 3032024080
- ISBN-13: 9783032024084
-
相關分類:
生物資訊 Bioinformatics
海外代購書籍(需單獨結帳)
相關主題
商品描述
This book offers an in-depth analysis of the EU regulation of genome edited plants and its compatibility with WTO law and the Comprehensive Economic Trade Agreement (CETA). It analyses in detail whether the EU authorisation procedures, labelling requirements and the EU's opt-out mechanism and its application to genome edited plants are compatible with the EU's obligations under the Agreement on Sanitary and Phytosanitary Measures (SPS Agreement), the Agreement on Technical Barriers to Trade (TBT Agreement), the General Agreement on Tariffs and Trade (GATT) and CETA. Based on this analysis, the EU Commission's proposal for a new regulation on plants produced by certain new genomic techniques is discussed. Also, the book provides suggestions to further improve the EU Commission's proposal. The book's analysis is not only relevant for legal researchers in the field of biotechnology and international economic law, but also discusses regulatory aspects that are highly relevant for the scientific and industrial sector involved in biotechnology.
商品描述(中文翻譯)
本書深入分析了歐盟對基因編輯植物的規範及其與世界貿易組織（WTO）法規和全面經濟貿易協定（CETA）的相容性。書中詳細分析了歐盟的授權程序、標籤要求以及歐盟的選擇退出機制及其對基因編輯植物的適用性，是否符合歐盟在《衛生與植物檢疫措施協定》（SPS 協定）、《技術性貿易障礙協定》（TBT 協定）、《關稅及貿易總協定》（GATT）和 CETA 下的義務。基於此分析，書中討論了歐盟委員會針對某些新基因技術生產植物的新規範提案。此外，本書還提供了進一步改善歐盟委員會提案的建議。本書的分析不僅對生物技術和國際經濟法領域的法律研究者具有相關性，還討論了對參與生物技術的科學和工業部門高度相關的監管方面。
作者簡介
Elisabeth Anna Lümkea Andersen graduated in law from the University of Freiburg in 2018. Already during her studies, she focused on public international law and the interrelations of science and law especially in the field of German and international patent law. From 2018 to 2022, she has been a legal researcher at the Centre for Integrative Biological Signalling Studies, Cluster of Excellence, University of Freiburg. Her research focused on international and EU biotechnology law and its interactions with WTO law and CETA as well as public international law. For her PhD thesis which she realised as part of the CIBSS project, she especially focused on the regulation of genome editing techniques and its application to plants in EU law, WTO law and CETA, also examining the EU Commission's plans to adopt new regulations in this field.
作者簡介(中文翻譯)
伊莉莎白·安娜·盧姆凱·安德森於2018年畢業於弗賴堡大學法學系。在她的學習過程中，她專注於公共國際法以及科學與法律之間的相互關係，特別是在德國和國際專利法領域。從2018年到2022年，她擔任弗賴堡大學整合生物信號研究中心（CIBSS）的法律研究員。她的研究重點是國際和歐盟生物技術法及其與世界貿易組織（WTO）法和《全面經濟貿易協定》（CETA）的互動，以及公共國際法。她的博士論文是作為CIBSS項目的一部分實現的，特別關注基因編輯技術的規範及其在歐盟法、WTO法和CETA中對植物的應用，並檢視歐盟委員會在該領域採納新規範的計劃。
